Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole and phosphate binder effectiveness in haemodialysis patients with hyperphosphataemia
ACTRN12610000437066Phase 4Completed
- Sponsor
- King Saud University
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pantoprazole in hyperphosphatemia (2 arms), sponsored by King Saud University. Primary endpoint: Difference in mean pre-dialysis plasma phosphate levels on and off pantoprazole. Started Jun 2010; status: completed.
02
Drugs
pantoprazole
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on ACTRN12610000437066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000437066.